• Belsroma, a new drug for Alzheimer’s induced insomnia, has been approved by the FDA thanks to the research done by CITrials. This new medication can help patients that suffer from mild-to-moderate Alzheimers. With the help of Belsroma, said patients can experience less disruption during sleep. This 4-week study had 285 participants, with significant improvement in Sleep Time (TST) and wake after sleep onset (WASO) measures compared to a placebo group.

    http://www.sbwire.com/press-releases/citrials-clinical-work-helps-merck-wins-alzheimers-label-claim-for-insomnia-drug-belsomra-1279356.htm